Trademark: 87646724
Status Date
Monday, March 30, 2020
Filing Date
Monday, October 16, 2017
Published for Opposition
Tuesday, January 2, 2018
Abandoned Date
Monday, March 30, 2020
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
Mar 30, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 30, 2020
Abandonment - No Use Statement Filed
Aug 20, 2019
Teas Change Of Correspondence Received
Aug 22, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2019
Extension 3 Granted
Aug 20, 2019
Extension 3 Filed
Aug 20, 2019
Teas Extension Received
Feb 22, 2019
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2019
Extension 2 Granted
Feb 20, 2019
Extension 2 Filed
Feb 20, 2019
Teas Extension Received
Aug 22, 2018
Notice Of Approval Of Extension Request E-Mailed
Aug 20, 2018
Extension 1 Granted
Aug 20, 2018
Extension 1 Filed
Aug 20, 2018
Teas Extension Received
Feb 27, 2018
Noa E-Mailed - Sou Required From Applicant
Jan 2, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 2, 2018
Published For Opposition
Dec 13, 2017
Notification Of Notice Of Publication E-Mailed
Nov 26, 2017
Assigned To Lie
Nov 9, 2017
Approved For Pub - Principal Register
Nov 9, 2017
Examiner's Amendment Entered
Nov 9, 2017
Notification Of Examiners Amendment E-Mailed
Nov 9, 2017
Examiners Amendment E-Mailed
Nov 9, 2017
Examiners Amendment -Written
Nov 3, 2017
Assigned To Examiner
Oct 25, 2017
New Application Office Supplied Data Entered In Tram
Oct 19, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
